Navigation Links
NIH fellow uses computation, experimentation to study diabetes, obesity
Date:8/2/2011

221.10.254.64

Stephanie Nicole "Nikki" Lewis, a graduate student in the interdisciplinary doctoral program in genetics, bioinformatics, and computational biology at Virginia Tech, has been awarded the prestigious Ruth L. Kirschstein National Research Service Award for Predoctoral Research through the National Institutes of Health for her study of a cellular signaling receptor that is associated with chronic inflammatory diseases such as diabetes, obesity, and inflammatory bowel disease.

Lewis is applying a combination of computational modeling and experimental methods to identify molecules that can activate peroxisome proliferator activated receptor gamma (PPAR ), which is a therapeutic target for suppressing inflammation. The search for drugs targeting the receptor is urgently needed since use of current drugs to treat type II diabetes by binding to PPAR , like the recently restricted Avandia (GlaxoSmithKline), results in adverse side effects. A goal of Lewis' research is to identify novel, orally active naturally occurring compounds with therapeutic potential due to their insulin-sensitizing and anti-inflammatory actions. The computational methods are used to quickly and inexpensively screen large numbers of compounds, from which a small number are selected for experimental validation in vitro and through pre-clinical animal studies.

This project entitled "Virtual Screening Development to Complement Experimental Screening for PPAR Modulators to Treat Type II Diabetes Mellitus" is primarily funded through the National Institute of Diabetes and Digestive and Kidney Diseases of NIH.

Lewis is working jointly with David Bevan, professor of biochemistry in the College of Agriculture and Life Sciences, and Josep Bassaganya-Riera, associate professor in the Nutritional Immunology and Molecular Medicine Laboratory at the Virginia Bioinformatics Institute (www.modelingimmunity.org).

"The strength of Nikki's research lies not only in the combination of computational and experimental methods, but also in her approach that will unravel details of the events that accompany PPAR  activation, thereby making the drug discovery process more rational," Bevan said.

"Nikki's successful NIH proposal builds upon ongoing collaborative research between Dr. Bevan and NIMML aimed at streamlining the drug and nutraceutical discovery process. In addition, Nikki's project leverages and extends the scope of studies conducted by the Center for Modeling Immunity to Enteric Pathogens. Specifically, this effort is in line with the goal of discovering novel broad-based immune therapeutics for gastrointestinal infectious diseases by creating computational models of the mucosal immune system and sets the stage for multi-scale modeling in drug discovery," Bassaganya-Riera said.


'/>"/>

Contact: Lori Greiner
lgreiner@vt.edu
540-231-5863
Virginia Tech
Source:Eurekalert  

Related biology news :

1. Green light for EU co-funding of TUM Institute for Advanced Study fellowships
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
3. Entomological Society of America names 2011 fellows
4. Weatherstone Fellows publish research as Autism Speaks announces 2011 Weatherstone Fellows
5. Top Latin-American scientists named 2011 Pew Fellows in the Biomedical Sciences
6. Rensselaer scholar receives NSF Research Fellowship
7. ASPB awards 15 summer undergraduate research fellowships
8. OGI awards summer research fellowships to 7 Ontario students
9. 5 UH graduates receive NSF fellowships for further study
10. Top Australian malaria researcher elected Fellow of the Royal Society
11. Fellowship to UC Riverside botanist encourages Hispanic students to take up research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH fellow uses computation, experimentation to study diabetes, obesity
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
(Date:1/28/2016)... (NASDAQ: SYNA ), a leading developer of human interface solutions, ... 2015. --> --> Net ... compared to the comparable quarter last year to $470.5 million. Net ... or $0.93 per diluted share. --> ... fiscal 2016 grew 9 percent over the prior year period to ...
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ... Market 2016-2020"  report to their offering. ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the addition ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, ... the promotion of two long-standing principal investigators (PI) to the roles of Chief ... and Development. , Dr. Laurence Chu, a Benchmark Research PI in the Austin ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare ... training and support program, Sonalink™ remote monitoring. The inaugural launch of this new ... February 5th, connecting Dr. Samuel Peretsman to a HIFU technical expert at SonaCare ...
(Date:2/10/2016)... ... February 10, 2016 , ... Global Stem Cells ... with Singapore-based Global Stem Cells Network (GSCN) and its affiliate Global Medical ... the latest adipose and bone marrow therapies. , Through the new collaboration, ...
(Date:2/9/2016)... ... 09, 2016 , ... With a presidential election in November and the future ... bring together over 500 top healthcare leaders for a night and day of debates ... by MBA students of the University of Pennsylvania’s Wharton School, will be held February ...
Breaking Biology Technology: